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Pulmonary immunological tolerance to inhaled par-
ticulates might create a permissive milieu for lung
metastasis. Lung microbiota contribute to pulmo-
nary tolerance; here, we explored whether its manip-
ulation via antibiotic or probiotic aerosolization
favors immune response against melanoma metas-
tasis. In lungs of vancomycin/neomycin-aerosolized
mice, a decrease in bacterial load was associated
with reduced regulatory T cells and enhanced T cell
and NK cell activation that paralleled a significant
reduction ofmelanomaB16 lungmetastases. Reduc-
tion of metastases also occurred in lungs trans-
plantedwith bacterial isolates from antibiotic-treated
lungs. Aerosolized Lactobacillus rhamnosus strongly
promoted immunity against B16 lung metastases as
well. Furthermore, probiotics or antibiotics improved
chemotherapy activity against advanced B16 metas-
tases. Thus, we identify a role for lung microbiota in
metastasis and show that its targeting via aerosoliza-
tion is a therapy that can prevent metastases and
enhance responses to chemotherapy.
INTRODUCTION
The lung microenvironment is characterized by a high immune
tolerance, which is essential for preventing excessive inflamma-
tion in response to inhaled particulates. This status is maintained
by lung antigen-presenting cells (APCs), primarily alveolar
macrophages (AMs) and dendritic cell (DC) subpopulations
(Hussell and Bell, 2014), which promote immunosuppression,
inducing regulatory T cells (Tregs) (Soroosh et al., 2013) and
the release of prostaglandin E2 (PGE2), transforming growth fac-
tor b (TGF-b), and interleukin (IL)-10 (Hussell and Bell, 2014). This
physiological immunosuppressive status could explain the high3528 Cell Reports 24, 3528–3538, September 25, 2018 ª 2018 The A
This is an open access article under the CC BY license (http://creativesusceptibility of the lungs to metastasis implantation from
various extrapulmonary neoplasms, including melanoma, breast
cancer, and colon cancer.
Lung microbiota are thought not only to provide resistance to
the colonization of respiratory pathogens but also to play a role in
the immune tolerance of the lung microenvironment, a hypothe-
sis supported by much evidence. In mice, increased bacterial
load in the lungs and the appearance of specific bacterial taxa
during the first two weeks after birth mediate the development
of Tregs through the microbe-induced polarization of lung den-
dritic cells (Gollwitzer et al., 2014). Moreover, the strong immune
activation observed in the airways of germ-free mice sensitized
and challenged intranasally with ovalbumin (OVA) is reduced af-
ter reconstitution with commensal bacteria (Herbst et al., 2011).
In humans, an attenuated immune response to lipopolysaccha-
ride (LPS) stimulation was reported for AMs in the presence of
a specific lung microbiota (Segal et al., 2016), and the presence
of Staphylococcus aureus, a lung commensal bacterium re-
ported to polarize alveolar CD11b+ monocytes to the M2-sup-
pressive phenotype, is essential for promoting resistance to
acute inflammation induced by influenza virus (Wang et al.,
2013). Moreover, members of the Bacteroidetes phylum have
been described to decrease lung inflammation (Larsen et al.,
2015), while the lung bacteria Prevotella spp. and Veillonella
spp. are associated with increased Th17 cell-mediated lung
inflammation (Segal et al., 2016). Furthermore, a study in HIV pa-
tients with pneumonia demonstrated that distinct lower-airway
microbiota are associated with specific local host immune re-
sponses (Shenoy et al., 2017).
Nasal sprays and aerosolization are efficient and non-invasive
methods to deliver molecules such as antibiotics (Zarogoulidis
et al., 2013), antibodies (Le Noci et al., 2016), cytokines (Storti
et al., 2015), Toll-like receptor agonists (Le Noci et al., 2015;
Sfondrini et al., 2013), and bacterial cells (Marchisio et al.,
2015) and therefore represent a strategy to locally modify the
lung microbiota, limiting the exposure of other organs. In mice,
bacterial 16S rRNA profiling revealed that the lung microbiome
was efficiently modified through nasal exposure, but not oraluthor(s).
commons.org/licenses/by/4.0/).
Figure 1. Effects of Antibiotic Aerosolization on the Lung Bacterial Microbiota and Tregs
Mice were treated for 5 days with aerosolized vancomycin and neomycin or with saline (4–5 mice/group).
(A) Bacterial load in 2 representative BAL samples collected aseptically 2 hr after the last treatment and plated on chocolate agar.
(B) Gating strategy and representative dot plots of Tregs (CD45+CD3+CD4+CD25+FoxP3+ live cells after doublet cell exclusion) in lung immune infiltrates
obtained from the digested lungs of saline- or antibiotic (vancomycin- and neomycin [Vanco/Neo])-treated mice. Bars (mean ± SEM) represent the percentage of
Tregs in the CD4+ T cell population (5 mice/group).
(C) IL-2 level (in picograms per milliliter) in BAL samples of 5 mice/group (ND, non-detectable).
(D–F) Representative overlay histogram plots and bars (mean ± SEM) showing the percentage of Ki-67-expressing Tregs (D), CCR4-expressing Tregs (E), and
IL-10-producing Tregs (F) (FMO, fluorescence minus one control) (5 mice/group).
*p% 0.05, **p% 0.01.exposure, to the antibiotic vancomycin, a glycopeptide used for
inhalation in patients (ClinicalTrials.gov: NCT01509339) (Barfod
et al., 2015), and nasal administration of lactobacilli was found
to stimulate respiratory immunity and to increase resistance
against viral infections (Harata et al., 2010; Youn et al., 2012).
In humans, inhaled antibiotics are used to treat critical lung infec-
tions (Geller, 2009), while the administration of Streptococcus
salivarius by nasal spray has been reported to prevent acute
otitis in children (Marchisio et al., 2015).
To our knowledge, no studies aiming to alter the pulmonary
microbiota, to subvert the immune-suppressive lung micro-
environment and to establish local immunity against cancer,
have been performed. In this study, we evaluated whether
the nebulization of antibiotics or probiotics to modify the lung
microbiota results in immunosurveillance against lung cancer
metastases.
RESULTS
Vancomycin and Neomycin Aerosolization Modifies
Lung Tissue Immunity and Prevents Tumor Implantation
To evaluate whether a reduction of the lung microbiota mitigates
the immunosuppressive status in the lung microenvironment,
micewere treated with broad-spectrum antibiotics by airway de-
livery. Specifically, micewere aerosolized with both vancomycin,
which is directed to Gram-positive bacteria, and neomycin,
which acts against several Gram-negative bacteria and partially
against Gram-positive bacteria, or with saline for 5 days. The
commensal bacterial load decreased in the bronchoalveolar
lavage (BAL) of antibiotic-treated mice (mean colony-forming
unit [CFU]/mL: 313.3 ± 173.7 in antibiotic-treated mice versus1,390 ± 152.4 in saline-treated mice, p = 0.0056) (Figure 1A).
Fluorescence-activated cell sorting (FACS) analysis of digested
lung suspensions revealed that the decrease in bacterial load
induced by antibiotic aerosolization did not significantly change
the percentage of T cells, natural killer (NK) cells, DCs, and AMs
infiltrating the lungs (Figure S1). Conversely, it resulted in a
reduction of the percentage of the tolerogenic population of
CD4+CD25+FoxP3+ Tregs (Figure 1B). This reduction was asso-
ciated with a drop in IL-2 level in BAL, a factor essential for
expansion and survival of Tregs, suggesting that the decline of
Tregs might be related to a reduced bioavailability of IL-2 in
the lung microenvironment (Figure 1C). A diminished fraction of
proliferating Tregs, defined by the expression of the Ki-67 prolif-
eration marker, was observed in antibiotic-treated lungs (Fig-
ure 1D), while no difference in CCR4 expression (Figure 1E), a
chemokine receptor involved in migration of Treg, was detected.
A decrease of IL-10-producing Tregs, a cytokine implicated in
their functional activity, was also observed ex vivo in lung sus-
pensions from antibiotic-treated mice (Figure 1F).
The effects of antibiotic treatment on the implantation of tumor
cells in the lungs were evaluated in mice pre-treated with aero-
solized antibiotics or saline for 2 weeks, intravenously (i.v.)
injected with B16 melanoma cells, and treated again with antibi-
otics for another 3 weeks. At the end of the treatment, the num-
ber of macroscopic melanotic metastases was significantly
reduced in antibiotic- versus saline-treated mice (p < 0.0001)
(Figure 2A). No overt signs of toxicity, such as weight loss,
hunching, ruffled fur, or difficulty breathing, were observed in
mice treated with antibiotics (Figure S2A). Histopathological ex-
amination of the lung tissues showed the absence of injury in the
lung parenchyma (Figure S2C).Cell Reports 24, 3528–3538, September 25, 2018 3529
Figure 2. Effects of Antibiotic Aerosolization on the Growth of Experimental B16 Lung Metastases and on the Activation of Lung Immune
Effector Cells
Mice were aerosolized with vancomycin and neomycin or saline for 2 weeks and then i.v. injected with B16 melanoma cells and aerosolized again for another
3 weeks (the scheme of the experiment is shown).
(A and B) Number of macroscopic metastases (A) in the lungs of mice treated with combined antibiotics or saline (9–10 mice/group) and (B) in mice treated to
compare the effects of the vancomycin and neomycin combination with those of each antibiotic (7–8 mice/group).
(C) Bars (mean ± SEM) representing the percentage of Tregs in the CD4+ T cell population from lung immune infiltrates of 4 mice/group aerosolized with saline or
combined vancomycin and neomycin.
(D) Representative overlay histogram plots and bars (mean ± SEM) showing the percentage of IL-10-producing Tregs.
(E) Gating strategy and representative dot plots and overlay histogram plots of NK cells (CD45+CD49b+CD3 cells) and T cells (CD45+CD3+CD49b cells) and
of CD69 expression in NK and T cell gates from mice aerosolized with saline or combined vancomycin and neomycin (4 mice/group) (FMO, fluorescence minus
one control).
(F) Bars (mean ± SEM) representing the percentage of NK cells, T cells, and CD69-expressing NK and T cells from 4–5 mice/group.
(G) Percentage of the specific lysis of NK-sensitive YAC target cells cultured for 4 hr with non-adherent cells obtained from the lung suspensions of 4 mice/group.
*p% 0.05, **p% 0.01, ***p% 0.001.To examine the effect of each antibiotic, the experiment was
repeated by treating the mice with vancomycin or neomycin
alone or their combination. A reduction in the number of B16
lung metastases was observed in both the vancomycin- and
the neomycin-treated groups, even if a significant decrease
compared to the saline-treated mice was achieved only in
the combination group (p = 0.395 in vancomycin-treated mice,
p = 0.053 in neomycin-treated mice, and p = 0.0464 in vancomy-
cin- and neomycin-treated mice versus saline-treated mice)
(Figure 2B).
FACS analysis of lung cell suspensions obtained frommice i.v.
injected with tumor cells and aerosolized with vancomycin and
neomycin or saline revealed no modulation of Tregs (Figure 2C),
but a significant reduction of IL-10-producing Tregs was found in
antibiotic-treated mice (Figure 2D). No difference in the percent-3530 Cell Reports 24, 3528–3538, September 25, 2018age and a strong upregulation of CD69 were observed in T cells
(Figures 2E and 2F), whereas both increased recruitment and a
strong upregulation of CD69were detectable in NK cells (Figures
2E and 2F). The increased recruitment and activation of NK cells
were associated with increased cytotoxic activity evaluated
in vitro against NK-sensitive YAC target cells (Figure 2G).
These results indicate that local antibiotic treatment reduces
the implantation of experimental lung metastases and that this
effect is associated with a modulation of the immune response.
Pulmonary Transplantation of Bacteria Isolated from
Vancomycin- and Neomycin-Treated Lungs Reduces
Tumor Implantation
16S rRNA gene profiling revealed that 5-day administration of
vancomycin and neomycin via aerosol significantly increased
Figure 3. Effects of Commensal Bacteria
Transplantation from Antibiotic-Treated or
Untreated Lungs on the Growth of Experi-
mental B16 Lung Metastases
(A) Bacterial strains were isolated from the BAL of
mice aerosolized for 5 days with vancomycin and
neomycin and from the BAL of untreated mice and
were taxonomically identified by 16S rRNA gene
sequencing.
(B) Number of macroscopic lung metastases in mice
aerosolized, starting 1 day before they were i.v. in-
jected with B16 cells, with saline (G1), or a combi-
nation of in vitro-cultivated bacterial strains isolated
from the BAL of vancomycin- and neomycin-treated
mice (G2) and in mice aerosolized with saline (G3) or
a combination of in vitro-cultivated bacterial strains
isolated from the BAL of untreated mice (G4) after
reducing their commensal flora through a 5-day
aerosolization with vancomycin and neomycin (5–6
mice/group).
***p% 0.001.(a) diversity in terms of bacterial richness, estimated by the num-
ber of observed operational taxonomic units (OTUs) and the
Chao1 index. On the contrary, no difference was observed
with indexes that estimate biodiversity while considering bacte-
rial evenness (i.e., Shannon, Simpson, and inverse Simpson).
At the taxonomic level, antibiotic treatment modified BAL mi-
crobiota, drastically reducing the population of the genus
Streptococcus, which are common Gram-positive Firmicutes
commensal of the respiratory tract; concomitantly, antibiotic
administration led to the expansion in BAL microbiota of the
generally less represented genera of the Gram-negative phylum
Proteobacteria. In addition, we found expansion of members of
the Gram-positive phylum Actinobacteria (Figure S3).Cell ReporTo assess the effect of bacteria
expanded upon antibiotic treatment on
metastasis growth, we treated or did not
treat mice with vancomycin and neomycin
as done previously and isolated bacterial
strains from the BAL. According to the
colony morphology, from the BAL of
antibiotic-treated mice, we isolated two
bacterial strains that were taxonomically
assigned to the Gram-negative Proteo-
bacteria taxa (Morganella morganii and Es-
cherichia fergusonii) (Figure 3A). In
contrast, the three strains isolated from
the BAL of the untreated mice were taxo-
nomically identified as Gram-positive Fir-
micutes species (two morphologically
and genetically different isolates of Paeni-
bacillus glucanolyticus and Bacillus clausii)
(Figure 3A).
To determine the effects of commensal
bacteria isolated from antibiotic-treated
or untreated lungs on metastasis growth,
a transfer experiment was performed.
Specifically, a group of mice was aerosol-ized for 3 weeks with a bacterial cells suspension of the
two strains isolated from the BAL of mice treated with
vancomycin and neomycin aerosol (group G2), while another
group was aerosolized with saline (group G1). Conversely, to
assess whether the strains isolated from the untreated lungs
were able to reverse the antitumor effect of antibiotic
treatment, the third and fourth groups of mice were treated
by 5-day aerosolization with vancomycin and neomycin to
reduce their commensal flora and then aerosolized with a
combination of the three bacterial strains isolated from
untreated mice (group G4), to re-colonize their lungs, or
with saline (group G3). All groups were i.v. injected with
B16 melanoma cells 24 hr after the first bacterial or salinets 24, 3528–3538, September 25, 2018 3531
Figure 4. Effects of Probiotic Aerosolization
on the Growth of Experimental B16 Lung
Metastases and on the Maturation of Lung
Antigen-Presenting Cells
Mice were aerosolized with L. rhamnosus or saline
for 2 weeks and then i.v. injected with B16 mela-
noma cells and aerosolized again for another
3 weeks (the scheme of the experiment is shown).
(A) Number of macroscopic lungmetastases in the
mice at the end of the experiment (7–8 mice/
group).
(B) Gating strategy to analyze alveolar macro-
phages (AMs) (CD11c+FL-1+ cells among live
CD11blow cells; the FL-1 channel was reserved
for the assessment of autofluorescence), CD103+
DCs (CD103+MHC class II+ in CD11c+CD11blow
cells gated among live FL-1 cells), and CD11b+
DCs (CD11b+CD11c+ cells gated among live
FL-1 cells).
(C) Overlay histogram plots of CD80- and CD86-
expressing CD103+ DCs; of CD80, CD86, and
MHC class II-expressing CD11b+ DCs; and of
CD80, CD86, and MHC class II-expressing AMs in
the lung immune infiltrates of B16 tumor-bearing
mice aerosolized with saline or L. rhamnosus. Bars
(mean ± SEM) represent data from 3–4 mice/
group (FMO, fluorescence minus one control).
*p% 0.05.aerosolization, and the number of lung metastases was
counted 3 weeks later. A significant reduction in the number
of metastases was observed in the group aerosolized with
bacteria isolated from antibiotic-treated lungs (group G2)
versus that from the saline-treated group (group G1)
(p = 0.0005) (Figure 3B). Moreover, as shown in the figure,
antibiotic aerosol treatment, even when limited to the 5 days
before tumor injection, significantly reduced the implantation
of lung metastases (group G3), but re-colonization of anti-
biotic-treated mice by aerosolization of commensal bacteria
isolated from the lungs of untreated mice (group G4) attenu-
ated the protective effect of antibiotic treatment compared
to saline-treated mice (Figure 3B).
These results exclude a direct effect of the antibiotics on tumor
implantation and growth and indicate that resident bacteria con-
trol tumor implantation in the lung by influencing the immune
landscape of the lung tissue.3532 Cell Reports 24, 3528–3538, September 25, 2018Aerosolized Lactobacillus
rhamnosus Probiotic Promotes an
Immune Response that Prevents
Tumor Implantation in the Lungs
Our data indicate that aerosolization of
bacteria isolated from lung microbiota of
antibiotic-treated mice reduces lung
metastasis implantation. Thus, because
these bacteria include opportunistic
pathogen species that typically arise after
antibiotic treatment, we evaluated
whether the immunosuppressive effects
of the resident microflora can be over-
come by the aerosolization of safe bacte-ria with immunostimulatory properties such as Lactobacillus
rhamnosus GG, which reportedly enhances cell-mediated im-
munity by intranasal administration in viral infection models (Har-
ata et al., 2010; Youn et al., 2012). Aerosolized L. rhamnosus GG
reached the lung in a viable form (Figure S4) and significantly
reduced the number of lung metastases compared to saline
treatment when aerosolized for 2 weeks before B16 melanoma
cells were i.v. injected and for the 3 weeks before sacrifice (Fig-
ure 4A). No weight loss or other signs of toxicity and no injury to
the lung parenchyma were observed (Figures S2B and S2C).
Numerous reports have shown that Lactobacillus spp. may
mediate anticancer effects through DC maturation (Mohamad-
zadeh et al., 2005). In agreement, as shown in Figures 4B and
4C, analysis of lung suspensions from mice i.v. injected with
B16 tumor cells and aerosolized with L. rhamnosus revealed
that this treatment enhanced the maturation of AMs and of
CD103+ DCs and CD11b+ DCs, the two major DC populations
Figure 5. Effects of Probiotic Aerosolization
on the Tumor Immune Microenvironment
Mean relative expression ± SEM of IL-10, IL-12,
IDO, TGF-b1, PGE2, IRF4, and IRF5 mRNA levels,
evaluated by real-time PCR in the adherent cell
fraction of digested lungs from mice aerosolized
with L. rhamnosus GG or saline for 2 weeks before
and 3 weeks after they were i.v. injected with B16
melanoma cells (4–8 mice/group). Results are
presented as 2DCt. *p% 0.05, ***p% 0.001.residing in the lung that are involved inmigration to the lymph no-
des for tumor-derived antigen presentation (Sung et al., 2006);
however, no increase was detected in the percentage of these
three populations (data not shown). Specifically, the expression
of CD80 and CD86 maturation markers on CD103+ DCs was
significantly upregulated, CD11b+ DCs displayed higher positiv-
ity for major histocompatibility complex class II (MHC class II)
molecules, and there was a trend suggesting the upmodulation
of CD80 and CD86 (Figures 4B and 4C). Moreover,
L. rhamnosus significantly upregulated CD80 on AMs (Figures
4B and 4C). The increased maturation of CD103+ DCs and
AMs following the aerosolization of L. rhamnosus was also
observed in the lungs of tumor-free FVB mice (data not shown),
indicating that the maturation of resident APCs by L. rhamnosus
increased in the absence of tumor cells and that this effect was
not restricted to the specific reactivity of APCs in C57BL/6 mice.
Moreover, the maturation of resident APCs was associated with
reduced expression of M2 genes, as revealed by real-time PCR
analysis performed on mRNA extracted from the adherent cell
fraction of digested lungs that contains macrophages and
myeloid cells. M2-related genes, such as Il10, Ido, and Irf4,
significantly declined in adherent cells from the lungs of
L. rhamnosus-aerosolizedmice versus untreatedmice (Figure 5).
Moreover, there was a trend suggesting a reduction in TGF-b
and PGE2 expression. In contrast, M1 markers, such as IL-12
and IRF5, were significantly upregulated (Figure 5).
In contrast to that observed in antibiotic-treated lungs, no sig-
nificant reduction in the percentage of Treg was observed in lung
suspensions obtained from L. rhamnosus-treated mice (mean ±
SEM of the percentage of CD25+FoxP3+ cells in the
CD45+CD3+CD4+ fraction: 9.8 ± 0.8 in probiotic-treated mice
versus 11.2 ± 0.7 in saline-treated mice). No differences were
observed in the recruitment of NK cells or T cells in the lungs
of tumor-bearing mice between the two groups of mice (data
not shown). However, the increased expression of maturation
markers on APCs in B16 tumor-bearing lung suspensions fromCell Reportsmice aerosolized with L. rhamnosus was
associated with the enhanced expression
of CD69 on both T and NK populations
and with increased levels of the activa-
tory NK receptor NKG2D (Figure 6).
Depletion experiments confirmed the
role of NK cells in the antitumor effects
of L. rhamnosus in the low immunogenic
NK-sensitive B16 tumor model (Fig-
ure S5). However, we cannot excludethat L. rhamnosusmight also promote T cell-mediated cytotoxic
activity against immunogenic tumors.
These results suggest that aerosolized L. rhamnosus pro-
motes the maturation of resident APCs in the lungs and reduces
theM2microenvironment, resulting in the increased activation of
effector cells.
AerosolizationwithProbiotics or Antibiotics after Tumor
Implantation Increases Therapeutic Effects of
Dacarbazine
In addition to lactobacilli, Bifidobacterium is the probiotic genus
most frequently investigated for its immunomodulatory proper-
ties (Vlasova et al., 2016). In particular, the species B. bifidum,
which exclusively colonizes the healthy human colon (Turroni
et al., 2014), has been demonstrated to stimulate DC to acquire
Th1 stimulatory capacity (Guglielmetti et al., 2014). Thus, after
establishing its ability to significantly mature resident APCs in
the lungs when administered by aerosol (data not shown), the
strain B. bifidum MIMBb23sg was applied, and its effects were
compared to those of L. rhamnosus in subsequent experiments.
To investigate whether aerosolization with probiotics boosts
the immune response against a growing tumor after its implanta-
tion in the lung, we evaluated the efficacy of aerosolized lactoba-
cilli in a therapeutic protocol by initiating aerosolization 7 days
after tumor injection, when metastatic foci are detectable in the
lungs (Le Noci et al., 2016). This treatment was combined with
dacarbazine (DTIC), a conventional chemotherapeutic agent
used in metastatic melanoma patients that exerts immunostimu-
latory effects (Hervieu et al., 2013).
The mice were i.v. injected with B16 melanoma cells and
treated from day 7 to day 21 with DTIC alone or in combination
with aerosolized L. rhamnosus or B. bifidum. Two other groups
of mice received L. rhamnosus or B. bifidum alone, and one
group was left untreated. The antitumor effect of DTIC was
significantly increased when combined with L. rhamnosus or
B. bifidum (Figure 7A) with a comparable improvement, but no24, 3528–3538, September 25, 2018 3533
Figure 6. Effects of Probiotic Aerosolization on the Activation of
Lung Antitumor Effector Cells
Mice were aerosolized with L. rhamnosus or saline for 2 weeks and then i.v.
injected with B16 melanoma cells and aerosolized again for another 3 weeks.
Bars represent the percentages (±SEM) of CD69-expressing T cells and
of CD69- or NKG2D-expressing NK cells, pooled from 3–4 mice/group.
*p% 0.05. (The gating strategy was performed as described in the legend of
Figure 2.)significant effect was observed following treatment with each
probiotic alone. FACS analysis of cell suspensions obtained
from mice i.v. injected with tumor cells and then aerosolized
with L. rhamnosus revealed no differences in the recruitment of
NK cells or T cells (data not shown); nonetheless, a significant
increased CD69 expression was observed in both NK and
T cells in DTIC and probiotic- versus DTIC-treated mice (Fig-
ure 7B). This increased activation of effector cells was associ-
ated with a higher ability to lyse B16 tumor cells (Figure 7C).
Because the preceding experiments revealed that a reduction
in the commensal lung microbiota promoted immune activation,
we next evaluated whether aerosolization with antibiotics
improved the antitumor efficacy of DTIC in the therapeutic proto-
col. A significant increase in the antitumor effect of DTIC was
observed in mice i.v. injected with B16 melanoma cells and
treated as described previously from day 7 to day 21 with the
chemotherapeutic drug and aerosolized vancomycin and
neomycin (Figure 7D). Increased cytotoxic activity was observed
against B16 target cells in lung suspensions from mice treated
with DTIC and vancomycin and neomycin compared to those
from mice treated with DTIC alone (Figure 7E).
These results suggest that the local administration of immu-
nostimulatory probiotics or the reduction of immunosuppressive
commensal species by antibiotics improves the antitumor effect
of DTIC.
DISCUSSION
In this proof-of-concept study, we demonstrate that the
commensal lung microbiota are manipulated by antibiotic or
probiotic aerosolization and that changes induced by these
treatments are associated with a reduction in the immune sup-
pression present in the lung microenvironment, thus favoring
an immune response against cancer cells.
Antibiotic aerosolization is a compelling strategy used to
achieve high antibiotic concentrations in the airway to maximize
bacterial killing with minimal systemic side effects (Zarogoulidis3534 Cell Reports 24, 3528–3538, September 25, 2018et al., 2013). Antibiotic aerosolization has been revealed to be
safe and to have a significant impact on clinical outcomes in
the treatment of chronic respiratory tract infections in patients
with cystic fibrosis (Geller, 2009). Moreover, pulmonary adminis-
tration of antibiotics has the advantage of minimally affecting gut
microbiota, avoiding the intestinal dysbiosis reported to play a
critical role in systemic immunity (Belkaid and Naik, 2013) and
eventually to increase the frequency (Boursi et al., 2015; Fried-
man et al., 2006; Velicer et al., 2004) and the growth (Cheng
et al., 2014; Rossini et al., 2006) of tumors.
Here, we observed that the decrease in the lung bacterial flora
resulting from antibiotic aerosolization reduced tumor implanta-
tion in the lung and that this treatment increased the activation of
NK and T effector cells. In contrast to results obtained in non-
tumor-bearing mice, which showed a reduction of the Treg per-
centage and of IL-10-producing Tregs, antibiotic treatment in
tumor-bearing lungs did not reduce the percentage of Tregs
but significantly diminished the percentage of IL-10-producing
cells. This result might be related to the presence of tumor cells
in the lung that are known to modulate Treg expansion and
recruitment through cytokine and chemokine production. Tregs,
regardless of their antigenic specificity, establish a state of domi-
nant and stable tolerance through a bystander effect (Tang and
Bluestone, 2008) that limits effector T cell activation against
tumor cells. Because a significant reduction of lung metastases
was achieved only using combined wide-spectrum antibodies, it
is plausible that the decrease of Tregs induced by aerosolization
is due to the reduction or elimination of combinations of signaling
pathways activated by different microbe-associated ligands in
the lung microenvironment. In agreement with our results,
endogenousmicrobiota have been reported to drive suppressive
cells in pancreas, and bacterial ablation by antibiotic treatment
has been demonstrated to promote an antitumor immune
response in pancreatic cancer by reducing the immunosuppres-
sive microenvironment (Pushalkar et al., 2018).
Numerous bacteria, many not previously recognized using
culture-dependent analysis, have been demonstrated to colo-
nize both mouse and human lungs by genomic approaches,
the most abundant of which are the Gram-positive firmicutes
and the Gram-negative bacteroidetes and proteobacteria phyla,
with the prominent genera being Streptococcus, Pseudomonas,
Veillonella, and Prevotella (Dickson et al., 2016). Few studies
have analyzed the immunological properties of bacterial compo-
nents in the lung, and whether specific taxa or biotypes of
bacteria with dedicated functions that promote immunosuppres-
sion or immunostimulation exist in the lung remains virtually
unknown and difficult to define. Our results demonstrated a sig-
nificant reduction of metastases in lungs of mice aerosolized
with bacteria that arose in lungs of antibiotic-treated mice,
including the Gram-negative bacterial species Morganella
morganii and Escherichia fergusonii, ubiquitous opportunistic
pathogens taxonomically belonging to Proteobacteria phylum,
that might exert an immunostimulatory effect through their
typical production of virulence factors (Liu et al., 2016; Rimoldi
and Moeller, 2013).
Because Morganella morganii and Escherichia fergusonii
were not repeatedly expanded in both experiments, we can
speculate that the shift from Firmicutes to Proteobacteria, or
Figure 7. Effects of Dacarbazine and Aerosolized Probiotics or Antibiotics on the Growth of Experimental B16 Lung Metastases
Mice were i.v. injected with B16 melanoma cells and then left untreated or treated starting 7 days after tumor injection with dacarbazine (DTIC) administered i.p.
alone or with aerosolized probiotics or antibiotics (the scheme of each experiment is shown).
(A) Number of macroscopic lung metastases in B16 melanoma-injected mice untreated or treated with L. rhamnosusGG, B. bifidumMIMBb23sg, DTIC alone, or
DTIC combined with aerosolized L. rhamnosus GG or B. bifidum MIMBb23sg (6–7 mice/group).
(B) Bars (mean ± SEM) representing the percentage of CD69-expressing NK and T cells from 4–5 mice/group treated with DTIC alone or combined with
aerosolized L. rhamnosus GG.
(C) Percentage (mean ± SEM) of the specific lysis of B16 target cells cultured for 4 hr with non-adherent cells obtained from lung suspensions of DTIC or DTIC and
L. rhamnosus-treated mice (3 mice/group).
(D) Number of macroscopic lung metastases in mice injected as described earlier and untreated or treated with DTIC alone or combined with aerosolized
vancomycin and neomycin (8 mice/group).
(E) Percentage of the specific lysis of B16 target cells cultured for 4 hr with non-adherent cells obtained from lung suspensions of DTIC or DTIC-, vancomycin-,
and neomycin-treated mice (6 mice/group).
*p% 0.05, **p% 0.01, ***p% 0.001.other Gram-positive microbes commonly induced by antibiotic
treatment, rather than specific species, is relevant to the reduced
immunosuppression. These findings point to a role of lung bac-
teria in antitumor immune response and suggest that a balance
among different bacteria is critical for antitumor immune re-
sponses. Accordingly, local administration of bacteria such as
L. rhamnosus, a Gram-positive lactic acid bacterium considered
a stable commensal of the oral microbiota and an allochthons in-
testinal bacterium in humans (Badet and Thebaud, 2008; Walter,
2008), was found to overcome immunosuppressive signaling
derived from commensal microbes. This bacterium is regarded
as safe and extensively performed for food products and supple-
ments, and it has already been shown to stimulate respiratory
immunity in mice when intranasally administered (Harata et al.,
2010; Youn et al., 2012). The reduction of lung metastasis im-
plantation induced by aerosolized L. rhamnosus was associated
with increasedmaturation of resident APCs, reduced expression
of M2 genes, and activation of T and NK cells in the lung,
whereas the percentage of Tregs was only lightly modified.
Increased activation of APCs, resulting in the promotion of
type 1 immune responses, has also been reported in humans
following in vitro incubation of L. rhamnosus with mononuclear
cells derived from healthy blood donors (Fong et al., 2015).
Thus, two strategies tomodify the lungmicrobiota—that is, aero-
solization of antibiotics or probiotics—promote similar antitumor
activity with different immune mechanisms. The activation ofantitumor effector cells by antibiotics seems related to a pauper-
ization of microbial signals necessary to the recruitment of Tregs
in the lung, while probiotics appear to overcome commensal
bacteria-induced tolerance, promoting the maturation of resi-
dent APCs.
A boost of immune response induced by the two strategies
similarly improved the response to treatment with DTIC, a geno-
toxic drug shown to exert immune-mediated effects by promot-
ing NK cell cytotoxicity (Hervieu et al., 2013). Thus, targeting the
microbiota in the lung by aerosolization could represent a thera-
peutic intervention to maintain an immune microenvironment
that favors the immunostimulatory effects exerted by several
chemotherapeutic drugs (Zitvogel et al., 2008).
Altogether, our study reveals an unravel role of pulmonary mi-
crobiota in controlling tumor growth in the lung and points to the
promise of aerosolization with probiotics or antibiotics as a clin-
ical therapeutic procedure to prevent metastases in the lungs of
high-risk patients and to enhance the response of patients to
chemotherapy.EXPERIMENTAL PROCEDURES
Cell Lines and Reagents
B16 mouse melanoma cells and YAC-1 mouse lymphoma cells (ATCC) were
routinely maintained at 37C in a 5% CO2 atmosphere in DMEM (Gibco-
Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS,Cell Reports 24, 3528–3538, September 25, 2018 3535
Gibco-Thermo Fisher Scientific) and 2 mM glutamine (Lonza). Authentication
of the cell line was verified by short tandem repeat DNA profiling, and cultures
were regularly tested for mycoplasma using the mycoAlert Plus Kit (Lonza).
Vancomycin was provided by PharmaTex, and neomycin trisulfate salt
hydrate was purchased from Sigma-Aldrich. DTIC was provided by Medac.
51Cr (1 mCi) was purchased from PerkinElmer. Lactobacillus rhamnosus GG
and Bifidobacterium bifidum MIMBb23sg were grown anaerobically at 37C
in de Man-Rogosa-Sharpe (MRS) broth (Difco Laboratories) and cysteine-
MRS (cMRS) supplemented with 0.05% L-cysteine hydrochloride, respec-
tively. After growth, the cells were collected by centrifugation, washed,
counted by flow cytometry, diluted in saline solution (9 g/L NaCl) with 10%
(w/v) glycerol to a final concentration of 1 3 109 cell/mL, and stored at
80C until use.
Isolation of Bacteria and Lung Suspensions
BAL was performed in euthanized mice as described (Sfondrini et al., 2013).
The recovered BAL fluid was then centrifuged and plated on agar chocolate
medium to isolate commensal bacterial colonies. For details on the protocols
used to (1) evaluate the presence of L. rhamnosus GG in the BAL of
L. rhamnosus-aerosolized mice and (2) isolate and taxonomically identify bac-
terial strains from BAL of untreated or antibiotic-treated mice, see Supple-
mental Experimental Procedures.
Isolation of lung immune cells from the lungs of healthy or tumor-bearing
mice treated with antibiotics, probiotics, or saline was performed as described
(Le Noci et al., 2016). Cell suspensions were directly stained for flow cytometry
or plated to separate adherent and non-adherent cell fractions as described
(Sommariva et al., 2017).
Mice and Experimental Protocols
Female C57BL/6 mice, aged 6–8 weeks (Charles River), were maintained in
laminar flow rooms at constant temperature and humidity, with food and water
given ad libitum. The experiments were approved by the Ethics Committee for
Animal Experimentation of Fondazione IRCCS Istituto Nazionale dei Tumori,
Milan. To evaluate the effects of aerosolized antibiotic or probiotic on tumor
implantation, mice were treated with vancomycin and/or neomycin (5 days/
week at 12-hr intervals) or with L. rhamnosus GG (3 times/week), starting
2 weeks before they were i.v. injected with 5 3 105 B16 melanoma cells and
continuing throughout the experiment.
For depletion of effector cells, mice were i.v. injected with CD3 F(ab0 )2
fragments (145-2C11 f(ab0)2) (BioXcell) at a dose of 50 mg/day for 5 days/
week starting 1 day before tumor injection to deplete T cells or were intraper-
itoneally (i.p.) injected with 500 mg of a-NK1.1 antibody (PK136) (BioXcell)
1 day before tumor injection, followed by injection of 200 mg every 5 days
throughout the experiment, to deplete NK cells. The efficacy of cell depletion
was verified by staining peripheral blood leukocytes for specific subsets
after depletion. In therapeutic experiments, mice were i.v. injected with
5 3 105 B16 melanoma cells and treated starting 7 days after tumor cell
injection with antibiotics (vancomycin and neomycin) or probiotics
(L. rhamnosus GG or B. bifidum MIMBb23sg) alone or in combination with
DTIC, administered i.p. at 70 mg/kg (5 days/week). For details of aerosol
administration, see Supplemental Information. In all experiments, mice
were weighed and inspected for any sign of sufferance twice weekly and
euthanized at day 21 after tumor injection to count macroscopic lung metas-
tases. To exclude any effects of aerosolized antibiotics or probiotics on the
architecture and structure of the lung parenchyma, lung samples were
analyzed as described (Le Noci et al., 2016). All in vivo experiments were
repeated at least twice.
Pulmonary Microbiota Transplantation
The experiment was performed using four groups of mice: two groups were
aerosolized 3 times/week for 3 weeks with saline (group 1) or with bacteria
grown in vitro obtained from the BAL of mice treated for 5 days with
aerosolized vancomycin and neomycin (10 mL of saline with 10% glycerol
containing 109 units/mL of Morganella morganii and Escherichia fergusonii
at 33% and materials) (group 2). Two other groups were aerosolized with
vancomycin and neomycin for 5 days and then aerosolized with saline
(group 3) or with bacteria grown in vitro from the BAL of untreated mice3536 Cell Reports 24, 3528–3538, September 25, 2018(10 mL of saline with 10% glycerol containing 109 units/mL of Bacillus clau-
sii and two Paenibacillus glucanolyticus isolates at 14%, 17%, and 68%,
respectively) (group 4). All mice were i.v. injected with B16 cells 1 day after
the first treatment, and the number of melanotic foci was counted 3 weeks
later.
In Vitro Cytotoxicity Assays
The ability of effector immune cells from the lung immune infiltrates of mice to
promote antitumor activity was evaluated by measuring cytotoxic activity of
non-adherent cells obtained from the lung suspensions on 51Cr-B16 target
cells or NK-sensitive 51Cr-YAC-1 target cells as described (Sommariva et al.,
2017). The radioactivity of the supernatant (80 mL) was measured as described
(Di Modica et al., 2016).
Statistical Analysis
Differences among groups were compared using a two-tailed unpaired Stu-
dent’s t test and were considered significant at p % 0.05. All analyses were
performed using GraphPad Prism v.5.0 for Windows.
Intra-subject bacterial richness and evenness (a diversity) were analyzed
using five algorithms: observed OTUs, Chao1, Shannon, Simpson, and
inverse Simpson. Significance was estimated according to Mann-Whitney
U test (**p < 0.01, *p < 0.05). Inter-sample (b) diversity analysis was carried
out with the UniFrac algorithms. LEfSe analysis represent differences
between the two groups of mice at the taxonomic levels of phylum, class,
order, family, and genus (represented by the concentric circles moving
from the center of the cladogram). Analyses were performed using R
v.3.4.2.
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